Interestingly, the nutraceutical treatment significantly decreased PLIN-2 protein expression in the hepatic parenchyma, especially in rats with NASH, further confirming the effect of the nutraceutical treatment on lipid metabolism and accumulation. The gene discussed is PLIN2; the disease is metabolic dysfunction-associated steatohepatitis.